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ABSTRACT
Long-Term Opiate-Induced Adaptations in Lateral Paracapsular Neurons of the Basolateral
Amygdala
Sara Jane Werner
Neuroscience Center, BYU
Master of Science
Increases in basolateral amygdala (BLA) activity drive avoidance-seeking behavior that may be
associated with stress induced drug seeking. Activity of BLA pyramidal neurons is regulated by
local and paracapsular gamma aminobutyric acid (GABA) interneurons. The lateral paracapsular
interneurons (LPCs) border the external capsule, receive dense cortical/thalamic input and
provide feed-forward inhibition onto BLA principle neurons. The GABAergic LPCs also express
high concentrations of g-protein coupled µ-opioid receptors (MORs). Therefore, the effects of
opiates on LPC activity and local GABA release were examined. Fluorescently double labeled
LPCs were observed in glutamate decarboxylase (GAD) 65-mcherry/GAD67-green fluorescent
protein (GFP) transgenic mice. Whole-cell electrophysiology experiments demonstrated that
acute exposure to [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO; a synthetic selective
MOR agonist), reduced LPC firing and spontaneous inhibitory postsynaptic current (sIPSC)
frequency in LPCs, with no apparent effect on spontaneous excitatory currents (sEPSCs).
Current injection induced firing in LPC neurons, but less effectively than in saline controls.
Morphine-exposed mice (10mg/kg/day, across 5 days, 1-2 days off) had increased sIPSCs
compared to saline-injected controls, as well as enhanced adenylyl cyclase (AC) activity.
Together these data show that LPC neurons are a highly sensitive targets for opiate-induced
inhibition, and that long-term opiate exposure results in impaired LPC excitability, possibly
contributing to anxiety observed during opiate withdrawal.
Keywords: lateral paracapsular cells, basolateral amygdala, morphine, addiction, anxiety, muopioid receptors, chronic exposure, withdrawal, electrophysiology, whole-cell patch clamp

ACKNOWLEDGEMENTS
I would like to acknowledge and express gratitude to my committee members, Drs.
Jordan Yorgason, Sterling Sudweeks, and Scott Steffensen, who have trained and mentored me
throughout this process, and who have remained patient and understanding with changes that
were made along the way. I could not have done any of this without their support, skill, and
expertise to teach and guide me.
A project of this magnitude is rarely accomplished alone, so I would also like to
acknowledge and thank Natalie Johnson, Hillary Wadsworth, James Brundage, Elizabeth
Anderson, Joakim Ronstrom, Drs. Nicholas Graziane, and Yuval Silberman for their direct
assistance in the completion of this project. I would like to include additional thanks for the
indirect assistance of Bridget Wu, Isaac Ostlund, Ashley Sego, Dr. Kyle Bills, Andrew Payne,
Dr. Mona Hopkins, Roberta Barnes, E. Jane Werner, Dr. Michael A. Werner, and Kirk C. Harter,
all of whose support and encouragement made a significant difference in the completion of this
project.

TABLE OF CONTENTS

TITLE PAGE ................................................................................................................................... i
ABSTRACT.................................................................................................................................... ii
ACKNOWLEDGEMENTS ........................................................................................................... iii
TABLE OF CONTENTS ............................................................................................................... iv
LIST OF FIGURES ....................................................................................................................... vi
Long-Term Opiate-Induced Adaptations in Lateral Paracapsular Neurons of the Basolateral
Amygdala ........................................................................................................................................ 1
Materials and Methods .................................................................................................................... 2
Animals ....................................................................................................................................... 2
Brain Slice Preparation and Drug Application ............................................................................ 2
Immunohistochemistry ................................................................................................................ 3
Electrophysiology Recordings .................................................................................................... 4
Statistical Analysis ...................................................................................................................... 4
Results ............................................................................................................................................. 5
Characterization of LPC Neurons of the BLA ............................................................................ 5
MOR Activation Reduces LPCs Firing and sIPSCs ................................................................... 5
Morphine Withdrawal Reduces LPC Excitability....................................................................... 6
Multiple Morphine Exposures Increase Adenylyl Cyclase Activity in LPCs............................. 7
iv

Multiple Morphine Exposures Produces Adenosine A1 Receptor Sensitivity ............................ 7
Discussion ....................................................................................................................................... 8
BLA and LPC Involvement in Anxiety, Addiction, and Decision-Making Circuits .................. 8
Effects of Opioids and MOR Activation on LPCs .................................................................... 11
Effects of Adenylyl Cyclase on Ion Channels .......................................................................... 11
Conclusion................................................................................................................................. 14
References ..................................................................................................................................... 16

v

LIST OF FIGURES
Figure 1. Characterization of LPC Neurons of the BLA .............................................................. 29
Figure 2. Acute Effects of MOR Activation on sIPSCs and sEPCSs in LPCs via DAMGO
Application .................................................................................................................................... 30
Figure 3. Morphine Withdrawal Reduces LPC Excitability ......................................................... 31
Figure 4. Multiple Morphine Exposures Increase Adenylyl Cyclase Activity in LPCs ............... 33
Figure 5. Multiple Morphine Exposures Produces Adenosine A1 Receptor Sensitivity .............. 35

vi

Long-Term Opiate-Induced Adaptations in Lateral Paracapsular Neurons of the
Basolateral Amygdala
Opioid misuse and abuse have become a rising problem, not only in the United States,
but across the globe, with stress being a major factor for initial drug seeking and relapse in
addicts (Koob, 2008; Sinha, 2008; Varghese et al., 2015). The basolateral amygdala (BLA) is a
major relay center for stress effects and anxiety behavior. Increases in BLA principal neuron
activity result in avoidance behavior (McCall et al., 2017; Thielen & Shekhar, 2002), and BLA
inhibition decreases anxiety-like behavior (Felix-Ortiz et al., 2013; Nuss, 2015; Wang, Zhao,
Liu, & Fu, 2014). Principal BLA neuron activity is reduced by local inhibitory gamma
aminobutyric acid-producing (GABAergic) neurons distributed throughout the BLA proper, and
by dense clusters of feed-forward gamma aminobutyric acid (GABA) neurons located along the
BLA/external capsule border, including lateral intercalated or lateral paracapsular cells (LPCs;
Marowsky, Yanagawa, Obata, & Vogt, 2005; Sanders & Shekhar, 1995; Silberman, Shi, BrunsoBechtold, & Weiner, 2008; Woodruff & Sah, 2007).
While relatively little is known about this small group of cells, activation of LPC inputs
has been shown to reduce anxiety-like behavior (Silberman, Ariwodola, Chappell, Yorgason, &
Weiner, 2010), and inactivation results in impaired fear extinction (Skelly, Chappell, Ariwodola,
& Weiner, 2016). In contrast to other BLA neurons, LPC neurons highly express inhibitory μopioid receptors (MORs)(Likhtik, Popa, Apergis-Schoute, Fidacaro, & Paré, 2008). The MOR
belongs to a class of G-protein-coupled receptor (GPCR) that activates inhibitory Gi proteins
(Manglik et al., 2012). Acute activation of MORs results in inhibited adenylyl cyclase (AC),
resulting in reduced cyclic adenosine monophosphate (cAMP) levels (Sharma, Klee, &
Nirenberg, 1975), reduced protein kinase A (PKA) activity (Chan & Lufty, 2016) and activation
of an inhibitory conductances (North, Williams, Surprenant, & Christie, 1987; Winters et al.,
1

2017) to reduce neuronal activity. In contrast, long term opioid use and withdrawal is associated
with increases in AC function (Avidor-Reiss, Nevo, Levy, Pfeuffer, & Vogel, 1996; Bie, Peng,
Zhang, & Pan, 2005; Bonci & Williams, 1997), an effect that appears to depend on the subtype
of AC present in the cell (Watts & Neve, 2005). The purpose of the present study is to examine
the effects of acute (slice perfusion) opiate exposure and physiological adaptations to multiple
opiate exposures in LPC neurons.
Materials and Methods
Animals
Female heterozygous glutamate decarboxylase (GAD) 67-green fluorescent protein
(GFP) knock-in mice (Tamamaki et al., 2003) were bred with male homozygous GAD65mCherry knock-in mice (JAX#023140; Peron, Freeman, Iyer, Guo, & Svoboda, 2015) to create
double labeled mice on a mixed CD-1XC57/BL6 background. Mice were given ad libitum access
to food and water and maintained on a 12:12 h light/dark cycle. All protocols and animal care
procedures were in accordance with the National Institutes of Health Guide for the care and use
of laboratory animals and approved by the Brigham Young University IACUC. Mice used in
injection experiments were injected intraperitoneally (IP) with morphine (10mg/kg/day) or saline
for 5 consecutive days with a sterile needle. Animals were returned to their home cages
immediately following the injection and observed for a tail response (Bilbey, Salem, &
Grossman, 1960; Straub, 1911). Following a 24-48 hour withdrawal period, mice were sacrificed
and used in electrophysiology experiments.
Brain Slice Preparation and Drug Application
Isoflurane (Patterson Veterinary) anesthetized mice (30-45 days old) were killed by
decapitation and brains were rapidly removed, sectioned into 220 μm-thick coronal slices (Leica
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VT1000S, Vashaw Scientific), and incubated for 60 min at 34°C in preoxygenated (95% O2/5%
CO2) artificial cerebrospinal fluid (aCSF) consisting of (in mm) as follows: 126 NaCl, 2.5 KCl,
1.2 NaH2PO4, 1.2 MgCl2, 21.4 NaHCO3, and 11 d-glucose. Cutting solution also contained
either MK801 (10 µM; (5S,10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10imine; Abcam) or kynurenic acid (2 mM) for blockade of ionotropic glutamate receptors. After
incubation, the tissue was transferred to aCSF (34°C) with kynurenic acid (2 mM) for recording
inhibitory post-synaptic currents (IPSCs) or picrotoxin (100 µM) for recording excitatory postsynaptic currents (EPSCs). The following concentrations of drugs (acquired from either SigmaAldrich or Tocris Bioscience) were bath applied for slice electrophysiology experiments where
specified: [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO; 10 μM), naloxone (1 μM),
isobutyl methylxanthine (IBMX; 100 μM), N6-cyclopentyladenosine (N6CPA; 1 μM), 8cyclopentyl-1,3-dipropylxanthine (DPCPX; 300 nM).
Immunohistochemistry
Animals were anesthetized in 5% isoflurane prior to transcardial perfusion with 4%
paraformaldehyde (PFA). Brains were then carefully removed and placed in 4% PFA for 24 hrs
for continued fixation. Brains were then placed in a solution of 30% sucrose in 1x PBS until the
brains dropped to the bottom of the vial (~24-48 hrs). Brains were then flash frozen in dry ice
and mounted on a cold microtome stage. Brain slices (40 μm) were taken of the BLA and placed
in cryoprotectant (30% ethylene glycol, 30% sucrose, 0.00002% sodium azide, in 0.1 M PB) and
kept at -20°C until mounting. To mount slides, sections were placed on microscope slides and
dried ~5 minutes. Once dried, a drop of vectashield (Vector Laboratories) was placed on the
tissue, and a cover slip was placed on the slide. Slides were allowed to set overnight, and then
they were kept at 4°C until imaging. An Olympus FluoView FV1000 confocal microscope was
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used to image mounted slices. Brain slices were mounted on microscope slides and imaged at
20x using a 488nm excitation wavelength.
Electrophysiology Recordings
During experiments, slices were continually perfused with warm (37°C) aerated (95%
O2/5% CO2) aCSF. GABA neurons were identified by the presence of soluble GFP (GAD67) or
mcherry (GAD65) fluorescence on Olympus BX51 upright microscope using Micromanager 1.4
software with an Infinity 3S camera (Lumenera). Whole cell recordings were made from the
lateral paracapsular region of the amygdala using a Multiclamp 700B amplifier (Molecular
Devices, Sunnyvale, CA) at a holding potential of −60 mV. Glass pipettes (2.5–6 MΩ; PP-83
Micropipette Puller; Narishige) were filled with a potassium gluconate–based intracellular
solution containing (in millimolar): 110 K-gluconate, 10 KCl, 15 NaCl, 1.5 MgCl2, 10 HEPESpotassium salt, 0.1 EGTA, 2 Mg-ATP, and 0.2 Na-GTP, 10 Na2 Phosphocreatine tetrahydrate
(pH 7.4, 278 mOsm). Series resistance was monitored and maintained below approximately
15MΩ for inclusion in the analysis. LPCs were identified based on relative location and
fluorescence. Drugs were applied for 4–6 min. Data were filtered at the amplifier with a 4-pole
high-pass Bessel filter at 2–10 kHz. Recordings were sampled continuously at 5 kHz with an
Axon Digidata 1440A (Molecular Devices) and at 10 kHz using pClamp 10 (Axograph
Scientific).
Statistical Analysis
For cell-attached electrophysiology recordings, currents were analyzed in Clampfit
10 (Molecular Devices). Firing rates for baseline and post-drug conditions were measured across
a 2 min period. Statistics were performed using Prism 5 (GraphPad) and NCSS 8. Statistical
significance was determined for groups of 2 variables using a two-tailed Student's t test.
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Experiments with >2 groups with only one factor were tested for significance using a one-way
analysis of variance (ANOVA). When data were from multiple time points from the same
experiment, a repeated-measures ANOVA was performed. For experiments that examined
multiple factors, and possible interactions, two-way ANOVA or repeated-measures ANOVAs
were used. Tukey's HSD and Bonferroni correction methods were used for post-hoc analysis.
Results
Characterization of LPC Neurons of the BLA
Widefield and confocal images were taken of amygdala sections from GAD65mcherry/GAD67-GFP transgenic mice, allowing LPC neurons to be easily identifiable (Figure
1). Note dense clustering of GAD65/67 positive neurons along the dorsal and lateral BLA region
indicating LPC neurons. Similar neuronal populations are also found in the medial lateral (ML)
and medial paracapsular (MPCs) areas. These populations are distinct from other GAD65/67
positive populations of the main island. Neurons were easily identifiable by presence of GAD67GFP or GAD65-mcherry, and distinct clustering (Figure 1). During patch clamp recordings, we
were able to easily target these neurons.
MOR Activation Reduces LPCs Firing and sIPSCs
Whole cell recordings were performed in LPC neurons for initial characterization. Since
LPC neurons express MORs, the acute effects of the selective MOR agonist DAMGO (10 µM)
were tested during whole cell experiments via bath application. In current clamp mode, a current
ramp injection (0-150 pA, 3 sec) induced action potential (AP) firing in LPCs that was prevented
by DAMGO and returned upon wash (Figure 2A). Spontaneous IPSCs (sIPCS) were observed in
LPCs, and DAMGO reduced sIPSC frequency (RM-ANOVA, F2,12=7.074, p = .0093, with
Tukey’s post-hoc analysis, BL vs. DAMGO, p < .01, BL vs. NALOXONE and DAMGO vs.
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NALOXONE, p = ns), which is reversed by the non-selective antagonist naloxone (1 µM; Figure
2C). However, sIPSC amplitude appeared unaltered (p > .05; Figure 2D). As sIPSC frequency is
affected and not amplitude, this would suggest that effects on LPC sIPSCs is presynaptic. Since
sIPSC frequency is reduced by not altogether silenced, sIPSCs may come from multiple sources
with reductions being largely due to inhibition of adjacent LPC neurons. Therefore, sIPSC
measurements are an indirect measure of neighboring LPC activity.
Next, spontaneous EPSCs (sEPSC) were recorded in LPCs. In contrast to effects
on sIPSCs, sEPSCs appeared unaffected by DAMGO (p > .05; Figure 2E-F), suggesting that
MOR effects on LPCs are mediated mostly by direct effects on LPC cell bodies, likely through
inhibition/activation of voltage dependent ion channels.
Morphine Withdrawal Reduces LPC Excitability
The effects of multiple morphine exposures and withdrawal on LPC activity were
examined. Mice received either saline or morphine IP injections for five consecutive days,
followed by a two-day withdrawal period. Current step depolarizations induced activity in LPC
neurons and LPC activity was recorded and analyzed (Figure 3A-G). In morphine-treated mice,
AP amplitude (54.76 ± 0.9106 mV) was greater than in saline-treated mice (46.16 ± 1.101 mV;
two-tailed, unpaired t test; t(272) = 5.878, p < .0001; Figure 3B). After hyperpolarization AP
area (AHP) was greater in morphine treated mice (-9.990 ± 0.4061 mV x ms to -5.588 ± 0.3909
mV x ms; two-tailed, unpaired t-test; t(273) = 7.78, p < .0001; Figure 3F), and morphine-treated
mice had shorter AP duration (1.587 ± 0.0564ms to 1.227 ± 0.0583 ms; two-tailed, unpaired t
test; t(273) = 4.42, p < .0001; Figure 3G). Thus, LPCs of morphine exposed mice are less
excitable than saline controls. Since AHP duration is increased and AP duration reduced in
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morphine treated mice (Figure 3F-G), these changes are likely due to increases in Kv channel
activity.
Multiple Morphine Exposures Increase Adenylyl Cyclase Activity in LPCs
Increased adenylyl cyclase activity is often observed during morphine
withdrawal (Johnson & Fleming, 1989) and is closely tied to activity of
intracellular phosphodiesterases (PDEs)(Conti & Beavo, 2007; Danchin, 1993). The PDE
inhibitor IBMX (100 µM) increased sIPSC frequency in morphine-treated mice (0.5449 ± 0.1282
Hz to 0.7175 ± 0.1650 Hz; one-tailed paired t test: t(7) = 4.033, p = 0.0025; Figure 4A-B). In
contrast, saline treated controls showed no significant difference after IBMX treatment (0.4023 ±
0.0704 Hz to 0.3645 ± 0.0747 Hz; one-tailed paired t test: t(3) = 1.358, p = 0.1338; Figure 4A-B).
Thus, inhibiting PDE activity elevates LPC activity selectively in morphine dependent animals,
likely through increased cAMP levels and subsequent effects on LPC membrane excitability.
Multiple Morphine Exposures Produces Adenosine A1 Receptor Sensitivity
Since PDE activity is affected by morphine exposure, and is associated with adenosine
tone, the effects of Gi coupled purinergic GPCR A1 receptor (A1R) activation was tested
(Cechova, Elsobky, & Venton, 2010). Morphine treated mice had a significantly
greater sIPSC inhibition in response to N6CPA (1 µM; A1R agonist) than saline-treated mice
(two-tailed, unpaired t test; t(13) = 3.397, p = 0.0048), with reversal by DPCPX (300 nM; A1
selective antagonist; Figure 5A-B). In morphine treated mice, N6CPA reduced sIPSC frequency
in morphine treated mice to 43.85 ± 6.72% baseline values (One-way ANOVA, F2,14 = 4.353, p
= .0339; Figure 5A). In saline controls, N6CPA had modest, but significant effects,
reducing sIPSC frequency to 77.72 ± 7.3% (F2,12 = 5.567, p = .0195; Figure 5A). Thus,
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A1R activation decreases sIPSC frequency likely via inhibition of LPC firing, with increased
A1 effects in morphine withdrawn mice.
Discussion
BLA cellular activity is involved in anxiety, addiction, reward and motivation, relapse,
and decision-making, and it is possible that LPC regulation of the BLA may be an underlying
mechanism behind these processes. (Davis, Rainnie, & Cassell, 1994; Felix-Ortiz et al., 2013;
Gale et al., 2004; Kroner, Rosenkranz, Grace, & Barrionuevo, 2005; Laurent & Westbrook,
2010; LeDoux, 2003; McCall et al., 2017; Sanders & Shekhar, 1995; See, Fuchs, Ledford, &
McLaughlin, 2003; Sharp, 2017; Skelly, Ariwodola, & Weiner, 2017). As LPCs are a major
source of feed-forward inhibition to principal BLA neurons, it is essential to understand their
reactivity to drugs of abuse (Marowsky et al., 2005). The LPCs uniquely express high levels of
µ-opioid receptors (MORs), further distinguishing their identity and chemical reactivity from
BLA pyramidal neurons and other GABAergic BLA cells (Jacobsen, Hoistad, Staines, & Fuxe,
2006; Zhang, Muller, & McDonald, 2015). Whole cell electrophysiology was used in BLA slices
to determine the significance of MOR activation on LPC neuronal activity. Data obtained
suggests an essential relationship between MOR activation and AC activity in regulation of LPC
activity and BLA circuitry, which could have important implications for human behaviors that
are dysfunctional as a result of long-term opioid use that may contribute to stress-induced opiateseeking behavior.
BLA and LPC Involvement in Anxiety, Addiction, and Decision-Making Circuits
Research has shown that the BLA is vital for emotional learning, fear conditioning,
anxiety behaviors, and addiction (Diaz, Chappell, Christian, Anderson, & McCool, 2011; Gale et
al., 2004; Huff, Emmons, Narayanan, & LaLumiere, 2016; See et al., 2003). Afferent and
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efferent projections to this area include ventral hippocampus (vHPC), prefrontal cortex (PFC),
and Nucleus Accumbens (NAc), which are associated with fear, anxiety, and interpreting
rewarding stimulus (Ambroggi, Ishikawa, Fields, & Nicola, 2008; Felix-Ortiz et al., 2013; FelixOrtiz, Burgos-Robles, Bhagat, Leppla, & Tye, 2016; Marek, Strobel, Bredy, & Sah, 2013; Senn
et al., 2014).
Studies have implicated the BLA’s involvement in anxiety and anxiety-related behaviors,
with increased anxiety-behaviors associated with increased BLA neuronal activity (Diaz et al.,
2011; Felix-Ortiz et al., 2013; McCall et al., 2017; Wang et al., 2014). It has been shown that
optogenetic inhibition of BLA pyramidal neurons results in significant increases in time spent in
the open-arm portion of an elevated plus maze, which is commonly accepted as an observed
reduction in anxiety (Felix-Ortiz et al., 2013). This effect was reproduced using the open-field
test, where a significant decrease in anxiety-associated behaviors was seen (Felix-Ortiz et al.,
2013). This effect was seen in seconds, as anxiety behaviors were reinstated to levels comparable
to control mice shortly before and after light-activation (Felix-Ortiz et al., 2013).
Furthermore, light activation of noradrenergic terminals in BLA resulted in increased
BLA principle neuron activity, which was behaviorally expressed by
increased avoidance behaviors and conditioned aversion (McCall et al., 2017). The open-field
anxiety test was used as a measure for anxiety behaviors. Upon light-activation of LC-NEs,
which corresponds to increased BLA levels of NE and increased BLA neuronal activity,
significantly less time was spent in the open compared to controls (McCall et al., 2017). This
suggests increased anxiety behaviors with increased BLA activity. Finally, a study demonstrated
that lesions to the BLA resulted in animals displaying significantly more anxiety-related
behaviors in the open-field, elevated-plus maze, and light-dark test (Wang et al., 2014).
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The BLA is also highly implicated in addiction behaviors. As with anxiety, increased
BLA activity is associated with increased displays of addiction-behaviors (Sharp, 2017).
Additionally, the BLA known to be associated with Pavlovian-type learning and acquisition of
appetitive behaviors, it is generally associated with mechanisms underlying addiction (Robbins,
Ersche, & Everitt, 2008; Sharp, 2017). To demonstrate this relationship, a rodent model was used
to study condition-cued reinstatement of cocaine. They determined that activity of the BLA was
integral to the reinstatement, or relapse, of drug use. This function was demonstrated by
lesioning or pharmacologically inactivating the BLA, which significantly attenuated
reinstatement behaviors. They also tested the effects of D1 receptor antagonists and found that
deactivation of D1 receptors in the BLA reduced reinstatement. Whereas, amphetamine infusions
into the BLA increased this behavior, suggesting that D1 receptor activation in the BLA is
associated with increased likelihood of reinstatement (See et al., 2003).
The BLA is also heavily implicated in decision-making processes, including those
surrounding risky and impulsive behavior (Bechara, Damasio, Damasio, & Lee, 1999; GhodsSharifi, St. Onge, & Floresco, 2009; Verdejo-García, Pérez-García, & Bechara, 2006). Decision
making is ongoing, as organisms tailor their decisions based on different factors, both
environmental and intrinsic, while analyzing the consequences of past decisions to help mediate
future ones. Most individuals are able to execute these innate processes without issue, yet those
with substance use disorders and addictive tendencies are thought to have impaired decision
making and associated impulsive behaviors (Crowley et al., 2010; Gonzalez, Schuster,
Mermelstein, & Diviak, 2015).
The BLA is an integral part of mediating reward and punishment with optimal decision
making (van Holstein, MacLeod, & Floresco, 2020; Winstanley & Floresco, 2016). The LPCs
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play a critical role in regulation of BLA activity, especially in an environment of acute and
chronic opioid exposure. They are a major feed-forward inhibitor of the BLA and uniquely
express greater levels of MORs than BLA pyramidal and GABAergic neurons, making them
uniquely sensitive to opioids.
Therefore, human behavioral issues resulting from opioid abuse, including addiction,
increased anxiety, and impaired decision-making abilities, may be related to or caused by
changes in LPC function, as a result of their high expression of MORs and their regulatory
influence on BLA circuitry.
Effects of Opioids and MOR Activation on LPCs
Consistent with previous studies, we observed LPC inhibition as a result of MOR
activation (Blaesse et al., 2015; Winters et al., 2017), resulting in decreased firing and sIPSCs
from nearby LPCs. Since sEPSCs were unaffected, this suggests that LPC were directly inhibited
by MOR activation (and not inhibited via loss of glutamatergic afferent activity), likely via
activation of GPCR associated K conductances (Blaesse et al., 2015; Winters et al., 2017).
Interestingly, no MOR-induced outward currents were observed in the present study, suggesting
that inhibition may be more directly associated with Kv conductance, or possibly voltage gated
Ca2+ channels. Furthermore, it was found that excitability of LPCs was reduced in chronic
morphine-withdrawal mice, with apparent increases in Kv conductance. From step-current
induced depolarizations, input resistance appeared to be changed in chronic morphine-withdrawn
mice (Figure 3A), which further supports changes in intrinsic ion channel function after long
term morphine exposure.
Effects of Adenylyl Cyclase on Ion Channels

11

The A1R is an autoreceptor for adenosine (Cechova et al., 2010; Chen, Lee, & Chern,
2014). It is Gi-coupled; its activation is associated with increased K+ channel activity (Kirsch,
Codina, Birnbaumer, & Brown, 1990), a reduction in voltage-gated Ca2+ channel activity (Liu &
Gao, 2007), reduction in cAMP levels by inhibition of AC, and reduced PKA (Carruthers et al.,
2001; Chen et al., 2014; Jeong, Jang, Nabekura, & Akaike, 2003). Neuronal levels of adenosine,
the primary endogenous agonist of A1Rs, result from exonucleotide interactions with ATP,
making adenosine receptor activity an indirect measure of ATP tone in the brain (Chen et al.,
2014). As such, adenosine and adenosine receptors serve as significant modulators of neural
activity by affecting the release of neurotransitters, such as glutamate, GABA, acetylcholine
(ACh), and dopamine (DA)(Sebastião & Ribeiro, 1996). Opioid withdrawal is known to increase
adenosine and A1 activation in various regions of the brain, resulting in reduced neuronal activity
(Bonci & Williams, 1996; Matsui, Jarvie, Robinson, Hentges, & Williams, 2014; Shoji, Delfs, &
Williams, 1999). Adenosine and A1R activity are associated with negative side effects of longterm opioid use for pain management, such as dependance and addiction (Ahlijanian &
Takemori, 1985; Contreras, Germany, & Villar, 1990; Germany, Villar, Quijada, & Contreras,
1990; Trang et al., 2015). A1R sensitization is also a known effect of chronic opioid use and
withdrawal (Bonci & Williams, 1996). The present study showed that IBMX application
significantly increased sIPSCs in LPCs, likely through an increase in cAMP (a known effect of
IBMX). As A1R receptor sensitization in other areas of the brain is already a well-known effect
of chronic opioid use (Ahlijanian & Takemori, 1986), and that A1R activation results in
inhibition of AC and reduction of cAMP and PKA activity (Carruthers et al., 2001; Chen et al.,
2014; Jeong et al., 2003). Since IBMX and N6CPA both have increased effects in morphine
exposed mice, LPC activity is modulated by AC activity, cAMP levels, and downstream ion
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channel effects through enhanced PKA activity. These downstream effects on ion channels likely
include enhanced voltage-gated K+ and Na+ channel function (Cerda & Trimmer, 2010; Kirsch et
al., 1990; Scheuer, 2011), and may be responsible for changes in AP kinetics observed presently.
As shown in our recordings, activation of AC through IBMX application
increases sIPSC frequency in morphine dependent animals, indicative of increased GABA
release. Due to the characterized upregulation of AC during opioid withdrawal, there is a similar
increase in cAMP and subsequent PKA activity (Chan & Lufty, 2016). The increase in GABA
release seen is likely through the effects of PKA on LPC membrane excitability. PKA, widely
expressed throughout the brain, is an effective modulator of neuronal targets, including ion
channels, through phosphorylation (Lein et al., 2007).
Small conductance Ca2+ -activated K+ (SK1-3) channels are one potential target of PKA.
These channels are shown to regulate neuronal firing frequency in various parts of the central
nervous system by contributing to the afterhyperpolarization (AHP) of an action potential
(Köhler et al., 1996; Schwindt, Spain, & Crill, 1988). Previous research has shown that SK
channels are direct phosphorylated targets of PKA, and that activation of PKA results in a
decrease of SK2 channels in the plasma membrane of COS7 cells (Ren et al., 2006). In our
proposed morphine model, PKA activation may similarly result in a reduction of SK channels in
LPCs, leading to reduced AHP, greater neuronal excitability and subsequent GABA release.
Voltage-gated calcium channels are also important players in neurotransmitter release
and are similarly targets of PKA. A large body of research has shown that PKA activity affects
L-type calcium channels, an interaction that has vast consequences on cardiac function (Bodi,
Mikala, Koch, Akhter, & Schwartz, 2005). It is less well-known, however, the role PKA may
have on P/Q- and N-type calcium channels, channels known to mediate synaptic transmission
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(Dunlap, Luebke, & Turner, 1995). Research has shown that other kinases, such as protein
kinase C (PKC), enhance N-type calcium conductance and contribute to enhanced
neurotransmitter release (Su et al., 2012). Although not directly shown, it is possible that PKA
activation may have a similar effect in regulating neuronal activity in the morphine model we
have presented.
Another target specifically of cAMP is Epac (exchange protein directly activated by
cAMP). Epac1 and Epac2, found within the CNS, are guanine nucleotide exchange factors for
Rap1, part of the Ras family of g-proteins, contributing to the effective activation of GPCRs (de
Rooij et al., 2000). Rap 1 can be directly activated through cAMP activation of Epac (Bos,
2003). Previous data has shown that Epac activation through cAMP results in potentiated
hormone release, and that this process mirrors that of neurotransmitter release in the brain (Li et
al., 2007), as Epac activity increases the probability of vesicular release (Gekel & Neher, 2008).
This could serve as another potential explanation in our morphine model where activation of AC,
increased cAMP levels, and subsequent Epac activity increases GABA release.
Conclusion
As previously discussed, it was demonstrated that acute MOR activation reduced LPC
firing (Figure 2A) and sIPSC frequency, and that chronic MOR activation and withdrawal
reduced LPC excitability. Together, these experiments demonstrate the significant inhibitory
effect that MOR activation, whether acute or chronic-withdrawal, has on LPCs. With decreased
LPC activity, we would predict a corresponding increase in BLA activity, a relationship that
research has already demonstrated (Kroner et al., 2005; Marowsky et al., 2005). This predicted
increase in BLA is known to be associated with increases in avoidance behaviors (Diaz et al.,
2011) and reinstatement of use preference involved in addiction (See et al., 2003).
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The data has also shown that multiple morphine exposures increase AC activity in LPCs
and produces adenosine A1R sensitivity, resulting in increased and decreased sIPSC activity
respectively. This suggests Gi binding to AC, whether as a result of A1R or MOR
activation, causes inhibition of the cAMP pathway, resulting in decreased sIPSCs in LPCs, and
that increases in cAMP result in the opposite effect. This suggests a common mechanism by
which LPC function is regulated, thereby affecting the function and regulation of BLA pyramidal
neurons.
The significance of understanding LPC function as a result of acute and chronicwithdrawal exposure to opioid use is paramount when considering the prevalence of drug abuse,
addition, and relapse in society. This study has shown that acute and chronic-withdrawal use of
morphine result in decreased and increased sIPSC frequencies, respectively, decreased firing,
and reduced excitability of LPCs, all of which correlates with increased BLA activity (Kroner et
al., 2005; Marowsky et al., 2005). With the combination of these findings and the knowledge that
LPC and BLA function play significant roles in drug addiction and relapse, it becomes clear that
pharmacological interventions targeting this system may prove to be beneficial treatment
options.
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Figure 1.
Characterization of LPC Neurons of the BLA

A

B

C

Note. This figure displays amygdala sections from GAD65-mcherry/GAD67-GFP transgenic
mice. Glowing is associated with GABAergic cells, with dense cluster of glowing being
identified as LPCs, MPCs, and MLs, depending on their location bordering the BLA.
*Figures A and B display amygdala sections from GAD65-mcherry/GAD67-GFP transgenic
mice, allowing LPC neurons to be easily identifiable. Note dense clustering of GAD65/67
positive neurons along the dorsal and lateral BLA region indicating LPC neurons. Similar
neuronal populations are also found in the ML and MPCs areas. Figure C is an illustration of
GABAergic circuitry in the BLA. Note connectivity of paracapsular neurons to local interneuron
of the BLA and their projections into the CeA.
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Figure 2.
Acute Effects of MOR Activation on sIPSCs and sEPCSs in LPCs via DAMGO Application

Note. This figure shows acute effects of DAMGO (MOR agonist) bath application on LPC
sIPSCs and sEPSCs from naïve mice, followed by reversal of MOR activation by NALOXONE
bath application (MOR antagonist).
*Figure A shows induced firing of LPCs, with reduction in firing seen with DAMGO application.
Figure B shows raw recording data of sIPSCs during baseline, DAMGO (10 µM) application,
and NALOXONE (1 µM), as recorded from whole cell patch-clamp onto LPCs. Figures B-D and
show sIPSC and sEPSC frequency and amplitude during various bath applications.
*A significant reduction was seen in sIPSC frequency during bath application of 10 µM
DAMGO (RM-ANOVA, < .01; Tukey’s post-hoc analysis, p < .01). No other group comparisons
showed statistically significant differences (RM-ANOVA, p > .05).
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Figure 3.
Morphine Withdrawal Reduces LPC Excitability

Note. This figure shows induced activity in LPC neurons in chronic-morphine-withdrawn mice
via current step depolarizations. AP kinetics are also examined.
*Figure A shows raw tracings of LPC firing during current step depolarizations for saline or
morphine-withdrawn mice. Figure B shows an example of AP amplitude difference between
saline and morphine mice. C-G compares RMP, number of APs, AP burstiness, AHP, and AP
duration between saline and morphine-withdrawn mice.
*In morphine-treated mice, AP amplitude (54.76 ± 0.9106 mV) was greater than in salinetreated mice (46.16 ± 1.101 mV; two-tailed, unpaired t test; t(272)= 5.878, p < .0001). After
hyperpolarization AP area (AHP) were greater in morphine treated mice (-9.990 ± 0.4061 mV x
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ms to -5.588 ± 0.3909 mV x ms; two-tailed, unpaired t test; t(273) = 7.78, p < .0001), and
morphine-treated mice had shorter AP duration (1.587 ± 0.0564 ms to 1.227 ± 0.0583 ms; twotailed, unpaired t test; t(273) = 4.42, p < .0001).
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Figure 4.
Multiple Morphine Exposures Increase Adenylyl Cyclase Activity in LPCs

Note. This figure shows effects of the phosphodiesterase inhibitor IBMX (100 µM) on LPC
neurons from control or chronic-withdrawal morphine mice. Inhibiting PDE activity elevates
LPC activity selectively in morphine dependent animals.
*Figure A shows raw tracings of sIPSCs for baseline vs. IBMX exposure in saline and morphinewithdrawn LPCs. B shows sIPSC frequency for saline and morphine-withdrawn mice during
baseline and IBMX exposure.
* IBMX increased sIPSC frequency in morphine-treated mice (0.5449 ± 0.1282 Hz to 0.7175 ±
0.1650 Hz; one-tailed paired t test: t(7)= 4.033, p = .0025). Saline treated controls showed no

33

significant difference after IBMX treatment (0.4023 ± 0.0704 Hz to 0.3645 ± 0.0747 Hz; onetailed paired t test: t(3) = 1.358, p = .1338).
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Figure 5.
Multiple Morphine Exposures Produces Adenosine A1 Receptor Sensitivity

Note. This figures shows sIPSC frequency for saline vs. morphine-withdrawn mice under
baseline, N6CPA, and DPCPX bath application conditions.
*Figure A shows quantitative analysis (bar graphs) of sIPSC frequency for baseline, N6CPA,
and DPCPX bath application conditions. Figure B shows raw current tracings of LPCs sIPSCs
from saline and morphine-withdrawn mice during baseline, N6CPA, and DPCPX bath
application conditions.
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*Morphine treated mice had a significantly greater sIPSC inhibition in response to N6CPA
(1uM; A1R agonist) than saline-treated mice (two-tailed, unpaired t test; t(13) = 3.397, p =
.0048), with reversal by DPCPX (300 nM; A1 selective antagonist). In morphine treated mice,
N6CPA reduced sIPSC frequency in morphine treated mice to 43.85 ± 6.72% baseline values. In
saline controls, N6CPA had no apparent only modest effects, reducing sIPSC frequency to 77.72
± 7.3% (F2,12 = 5.567, p = .0195).
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